217082-58-1
Chemical Structure
Apelin-13
- CAS No.: 217082-58-1
- Formula:C69H111N23O16S
- Molecular Weight:1550.83
InChIKey: XXCCRHIAIBQDPX-PEWBXTNBSA-N
SMILES: O=C(O)[C@H](CC1=CC=CC=C1)NC([C@H]2N(C([C@H](CCSC)NC([C@H]3N(C(CNC([C@H](CCCCN)NC([C@H](CC4=CNC=N4)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H]5N(C([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)N)=O)=O)CCC5)=O)=O)=O)=O)=O)=O)=O)CCC3)=O)=O)CCC2)=O
Biological Activity: Apelin-13 is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 is widely distributed in the central and peripheral nervous systems. Apelin-13 has vasodilatory and antihypertensive effects. Apelin-13 also can be used for researching type 2 diabetes and metabolic syndrome[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Apelin-13 | 99.61% | Apelin-13 is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 is widely distributed in the central and peripheral nervous systems. Apelin-13 has vasodilatory and antihypertensive effects. Apelin-13 also can be used for researching type 2 diabetes and metabolic syndrome. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Tatemoto, K., Hosoya, M., Habata, Y., et al. Isolation and characterizaton of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 251, 471-476 (1998). [Content Brief]
- [2]. Li M,et al. Apelin 13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high fat diet. Mol Med Rep. 2018 Dec;18(6):5784-5790. [Content Brief]
- [3]. Yamaleyeva LM, et al. Apelin-13 in blood pressure regulation and cardiovascular disease. Curr Opin Nephrol Hypertens. 2016 Sep;25(5):396-403. [Content Brief]
